Percutaneous nephrostomy versus ureteroscopic management of XXXX associated with ureteral stone impaction: a randomized controlled trial.

@entity1695 @entity1 @entity295
UNASSIGNED: A randomized trial was conducted prospectively to evaluate the efficacy, related complications, and convalescence of emergent retrograde ureteroscopic management, instead of percutaneous nephrostomy for decompression of the collecting system in cases of @entity295 associated with @entity1695 . A total of 107 @entity1 undergoing ureteroscopic stone manipulation for ureteral stones completed the study protocol, 53 @entity1 in the percutaneous nephrostomy group, and 54 @entity1 in the emergent retrograde ureteroscopic management group. The primary end point was the time to normalization of WBC of 10,000/mm or less and temperature of 37.4    C or less. The second end point was the comparison analgesic consumption, length of stay, and related complications. Statistical analysis was performed using SPSS(  ) version 14.0.1. The Mann-Whitney U test, Chi square test, and fisher's exact test was used as appropriate. The length of hospital stay (days) was 10.25      3.53 and 8.24      2.77 in the percutaneous nephrostomy group and emergent retrograde ureteroscopic management group, respectively, with significant difference (Table  2). However, @entity1 in the emergent retrograde ureteroscopic management group had a significantly higher rate of s body temperature (  C). Meanwhile, the analgesic consumptions are 31.51      11.16 and 40.00      14.54 in the percutaneous nephrostomy group and emergent retrograde ureteroscopic management group, respectively, with significant difference. Our results show that it can be effectively and safely managed by retrograde ureteroscopic management combined with strong antibiotics in select clinical situations. Ureteroscopic management should no longer be considered a contraindication for the treatment of @entity1 with @entity295 associated with obstructing ureteral stones.
